The future of active surveillance.
作者信息
Klotz Laurence
机构信息
Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
出版信息
Transl Androl Urol. 2018 Apr;7(2):256-259. doi: 10.21037/tau.2018.01.12.
Abstract
摘要
相似文献
1
The future of active surveillance.主动监测的未来。
Transl Androl Urol. 2018 Apr;7(2):256-259. doi: 10.21037/tau.2018.01.12.
2
Active surveillance of early prostate cancer: rationale, initial results and future developments.早期前列腺癌的主动监测：基本原理、初步结果及未来发展
Prostate Cancer Prostatic Dis. 2004;7(3):184-7. doi: 10.1038/sj.pcan.4500720.
3
Active Surveillance of Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: A Review of the Current Role and Future Perspectives.使用多参数磁共振成像对前列腺癌进行主动监测：当前作用和未来展望的综述。
Med Sci Monit. 2020 Apr 12;26:e920252. doi: 10.12659/MSM.920252.
4
Aligning evidence and practice: future research needs to increase utilization of active surveillance for favorable risk prostate cancer.使证据与实践相结合：未来的研究需要提高对低风险前列腺癌进行主动监测的利用率。
Curr Opin Urol. 2015 May;25(3):277-82. doi: 10.1097/MOU.0000000000000153.
5
Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.影响男性对低风险前列腺癌进行主动监测管理的因素。
Oncol Nurs Forum. 2009 Jan;36(1):89-96. doi: 10.1188/09.ONF.89-96.
6
Economic analysis of active surveillance for localized prostate cancer.局限性前列腺癌主动监测的经济学分析。
Curr Opin Urol. 2012 May;22(3):247-53. doi: 10.1097/MOU.0b013e328351dd32.
7
Active Surveillance in Small Renal Masses in the Elderly: A Literature Review.老年人群中小体积肾脏肿块的主动监测：文献回顾。
Eur Urol Focus. 2017 Oct;3(4-5):340-351. doi: 10.1016/j.euf.2017.11.005. Epub 2017 Nov 23.
8
Active Surveillance for Low and Intermediate Risk Prostate Cancer: Opinions of North American Genitourinary Oncology Expert Radiation Oncologists.主动监测低危和中危前列腺癌：北美泌尿生殖系统肿瘤学专家放疗肿瘤学家的观点。
Clin Genitourin Cancer. 2018 Apr;16(2):e323-e325. doi: 10.1016/j.clgc.2017.10.021. Epub 2017 Nov 7.
9
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.病理学家在确定前列腺癌患者主动监测作为一种管理选择的适用性方面的关键作用：美国病理学家学会、国际泌尿病理学会、解剖与外科病理学主任协会、新西兰病理学家协会和前列腺癌基金会支持的共识声明及建议
Arch Pathol Lab Med. 2014 Oct;138(10):1387-405. doi: 10.5858/arpa.2014-0219-SA. Epub 2014 Aug 5.
10
Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?十年来将主动监测标准应用于低风险甲状腺乳头状癌：可避免多少手术及并发症？
Thyroid. 2017 Apr;27(4):518-523. doi: 10.1089/thy.2016.0568. Epub 2017 Feb 22.
引用本文的文献
1
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer.血清衍生细胞外囊泡的蛋白质组学分析在前列腺癌中的诊断和预后潜力。
Cell Death Dis. 2021 Jun 21;12(7):636. doi: 10.1038/s41419-021-03909-z.
2
Copy number alterations are associated with metastatic-lethal progression in prostate cancer.拷贝数改变与前列腺癌转移致死进展相关。
Prostate Cancer Prostatic Dis. 2020 Sep;23(3):494-506. doi: 10.1038/s41391-020-0212-8. Epub 2020 Feb 18.
本文引用的文献
1
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.前列腺癌早期行前列腺切除术与观察治疗的随访研究。
N Engl J Med. 2017 Jul 13;377(2):132-142. doi: 10.1056/NEJMoa1615869.
2
Active Surveillance for Prostate Cancer: How to Do It Right.前列腺癌的主动监测：如何正确实施
Oncology (Williston Park). 2017 May 15;31(5):333-40, 345.
3
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance.主动监测管理的极低/低危和中危/高危前列腺癌男性的中期结果。
J Urol. 2017 Sep;198(3):591-599. doi: 10.1016/j.juro.2017.03.123. Epub 2017 Mar 24.
4
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.多参数磁共振成像在前列腺穿刺活检中排除前列腺癌的阴性预测值是多少？来自欧洲泌尿外科学会前列腺癌指南小组的系统评价和荟萃分析。
Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21.
5
Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis.前列腺影像报告和数据系统第 2 版检测前列腺癌的诊断性能：系统评价和诊断荟萃分析。
Eur Urol. 2017 Aug;72(2):177-188. doi: 10.1016/j.eururo.2017.01.042. Epub 2017 Feb 11.
6
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.胚系 BRCA2 突变驱动具有不同进化轨迹的前列腺癌。
Nat Commun. 2017 Jan 9;8:13671. doi: 10.1038/ncomms13671.
7
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.局限性前列腺癌监测、手术或放疗 10 年后的结果。
N Engl J Med. 2016 Oct 13;375(15):1415-1424. doi: 10.1056/NEJMoa1606220. Epub 2016 Sep 14.
8
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.主动监测中危前列腺癌：来自桑尼布鲁克经验的生存结果。
J Urol. 2016 Dec;196(6):1651-1658. doi: 10.1016/j.juro.2016.06.102. Epub 2016 Aug 26.
9
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.多参数MRI定量成像特征与MRI引导下前列腺穿刺活检中前列腺癌基因表达的相关性
Oncotarget. 2016 Aug 16;7(33):53362-53376. doi: 10.18632/oncotarget.10523.
10
Active Holistic Surveillance: The Nutritional Aspect of Delayed Intervention in Prostate Cancer.主动整体监测：前列腺癌延迟干预的营养方面
J Nutr Metab. 2016;2016:2917065. doi: 10.1155/2016/2917065. Epub 2016 May 5.
Zotero 插件